Clinical Trial Update: DARK STUDY "DysbetalipoproteinemiA and atheRoma Risk"

View source ↗

Summary

A clinical trial update for the DARK STUDY examining dysbetalipoproteinemia and atheroma risk; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysbetalipoproteinemia

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Dysbetalipoproteinemia | Status: UNKNOWN